The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review

To date, no consensus exists among stakeholders about switching patients between reference biological products (RPs) and biosimilars, which may have been curbing the implementation of biosimilars in clinical practice. This study synthesizes the available data on switching and assesses whether switch...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbier, Liese, Ebbers, Hans C., Declerck, Paul, Simoens, Steven, Vulto, Arnold G., Huys, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540323/
https://www.ncbi.nlm.nih.gov/pubmed/32236956
http://dx.doi.org/10.1002/cpt.1836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540323/
https://www.ncbi.nlm.nih.gov/pubmed/32236956
http://dx.doi.org/10.1002/cpt.1836

Ejemplares similares